Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Teladoc Health, Inc. (TDOC) SEC Filings & Earnings Calls

EquiReason read 18 Teladoc Health, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-25 — Chief Legal Officer Adam Vandervoort resigns effective Nov 1, 2026; will provide advisory services until Nov 1, 2027. Successor Jonathan Dorfman appointed. Resignation with good re.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TDOCTeladoc Health, Inc.Follow TDOC — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

25 Sep 20268-K · 5.02Chief Legal Officer Adam Vandervoort resigns effective Nov 1, 2026; will provide advisory services until Nov 1, 2027. Successor Jonathan Dorfman appointed. Resignation with good reason under severance agreement.open

Risks flagged

Key legal officer departure with 'good reason' may signal governance or strategic issues; transition risk.

“resignation was made with good reason under his executive severance agreement” · word for word
Read the original on SEC EDGAR ↗
31 Aug 20268-K · 5.02, 7.01Appointment of Michael Grasher as CFO, effective immediately. Brings insurance/financial services CFO experience. No financial metrics or guidance provided.open

Risks flagged

No material risk; CFO change is routine.

“No financial impact or guidance change disclosed.”
Read the original on SEC EDGAR ↗
13 Aug 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

Loss of long-tenured director (since 2014) may reduce board experience, but no disagreement indicates orderly transition.

“Mr. Snow has been a director of the Company since 2014 and the Company thanks him for his dedicated service.” · word for word
Read the original on SEC EDGAR ↗
3 Aug 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
30 Jul 202610-QTeladoc materially reduced BetterHelp revenue expectations for 2026 due to accelerated cash-pay user decline and insurance conversion constraints.open

Figures in the filing · each found in the filing text

U.S. Integrated Care Members · Integrated Care · Q2-2026100,300,000-2% y/y
Chronic Care Program Enrollment · Integrated Care · Q2-20261,272,000+14% y/y
Average Monthly Revenue Per U.S. Integrated Care Member · Integrated Care · Q2-2026$1.31+3% y/y
BetterHelp Paying Users · BetterHelp · Q2-2026346,000-11% y/y
Revenue · Q2-2026$607M-4% y/y
Net Loss · Q2-2026$-39M+19% y/y
Adjusted EBITDA · Q2-2026$66M-5% y/y
Free Cash Flow · H1-2026$9M-79% y/y

Guidance

BetterHelp revenue expectations materially reduced for 2026; restructuring costs expected $15M-$20M for FY2026

Management materially reduced BetterHelp revenue expectations for 2026 due to accelerated cash-pay decline and insurance conversion constraints.

Risks flagged

BetterHelp revenue decline accelerating

“During May 2026, the rate of decline in revenue from cash-paying users accelerated beyond the assumptions reflected in our previously expected results, and information available in late May and June indicated that the trend was more persistent and significant than previously anticipated.” · word for word

Insurance conversion capacity constraint

“Our ability to convert that demand into paying users, completed visits and revenue was constrained by the availability and capacity of providers who were appropriately licensed in the applicable state, credentialed and enrolled with the applicable payer, available to provide services and accepting new patients, as well as by insurance-specific eligibility, m” · word for word

Tariff exposure on imported components

“We expect tariffs on goods imported into the U.S. from Canada, Mexico, and China, and other countries upon which tariffs may be imposed, to continue to be met with retaliatory tariffs from those countries which would impact our consolidated results of operations as we import components for assembling welcome kits, refill kits, and replacement components for ” · word for word
Read the original on SEC EDGAR ↗
29 Jul 20268-K · 2.02Revenue $607M (-4% y/y); Net loss $-39M; Net loss per share $-0.21; Guidance: Lowered BetterHelp segment revenue outlookearningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$607M-4% y/y
Net loss · Q2-2026$-39M
Net loss per share · Q2-2026$-0.21
Adjusted EBITDA · Q2-2026$66M-5% y/y
Integrated Care segment revenue · Integrated Care · Q2-2026$394M+1% y/y
BetterHelp segment revenue · BetterHelp · Q2-2026$213M-12% y/y
Integrated Care adjusted EBITDA margin · Integrated Care · Q2-202616.5%
BetterHelp adjusted EBITDA margin · BetterHelp · Q2-20260.2%

Guidance

Lowered BetterHelp segment revenue outlook

BetterHelp revenue outlook lowered due to cash pay pressure; Integrated Care guidance maintained.

Risks flagged

BetterHelp cash pay revenue decline accelerated; insurance capacity constraint limits offset.

“Pressure on cash pay revenue accelerated further in late May and into June” · word for word
Read the original on SEC EDGAR ↗
30 Apr 202610-QRevenue $614M (-2% y/y); Net loss $-64M (-31% y/y); Adjusted EBITDA $58M (+0% y/y); Guidance: Restructuring costs guided $15M-$20M for FY2026open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$614M-2% y/y
Net loss · Q1-2026$-64M-31% y/y
Adjusted EBITDA · Q1-2026$58M+0% y/y
Integrated Care Adjusted EBITDA · Integrated Care · Q1-2026$56M+12% y/y
BetterHelp Adjusted EBITDA · BetterHelp · Q1-2026$2M-75% y/y
U.S. Integrated Care Members · Integrated Care · Q1-2026101,200,000-1% y/y
Chronic Care Program Enrollment · Integrated Care · Q1-20261,197,000+4% y/y
Average Monthly Revenue Per U.S. Integrated Care Member · Integrated Care · Q1-2026$1.30+2% y/y
BetterHelp Paying Users · BetterHelp · Q1-2026361,000-9% y/y
Free Cash Flow · Q1-2026$-26M+68% y/y

Guidance

Restructuring costs guided $15M-$20M for FY2026

Only restructuring cost guidance provided; no revenue or margin guidance.

Risks flagged

BetterHelp segment deterioration

“BetterHelp total revenue decreased by $21.5 million, or 9%, to $218.4 million for the three months ended March 31, 2026, driven by a 9% decrease in average monthly paying users.” · word for word

Goodwill impairment risk (BetterHelp)

“As of March 31, 2026, goodwill was $283.2 million, which all related to the BetterHelp segment. During the three months ended March 31, 2026, our market capitalization remained below the Company’s carrying or book value.” · word for word

Negative free cash flow

“Free cash flow was an outflow of $26.3 million for the three months ended March 31, 2026, compared to an outflow of $15.7 million for the three months ended March 31, 2025.” · word for word

Tariff cost pressure on medical device components

“We expect tariffs on goods imported into the U.S. from Canada, Mexico, and China... to impact our consolidated results of operations as we import components for assembling welcome kits, refill kits, and replacement components for our chronic care management solutions and virtual care devices.” · word for word
Read the original on SEC EDGAR ↗
29 Apr 20268-K · 2.02Revenue $614M (-2% y/y); Net loss $-64M (+31% y/y); Adjusted EBITDA $58M (+0% y/y); Guidance: Full-year 2026 revenue $2,481M-$2,576M; Adjusted EBITDA $267M-$306Mearningsopen

Figures in the filing · each found in the filing text

Revenue · consolidated · Q1-2026$614M-2% y/y
Net loss · consolidated · Q1-2026$-64M+31% y/y
Adjusted EBITDA · consolidated · Q1-2026$58M0% y/y
Free cash flow · consolidated · Q1-2026$-26M
Cash flow from operations · consolidated · Q1-2026$10M-40% y/y
Integrated Care segment revenue · Integrated Care · Q1-2026$395M+2% y/y
BetterHelp segment revenue · BetterHelp · Q1-2026$218M-9% y/y
U.S. Integrated Care Members · Integrated Care · Q1-202697,000,000

Guidance

Full-year 2026 revenue $2,481M-$2,576M; Adjusted EBITDA $267M-$306M

Full-year guidance reaffirmed; Q1 results exceeded midpoint; management optimistic about Integrated Care and scaling BetterHelp insurance acceptance.

Risks flagged

BetterHelp segment revenue decline continues, indicating potential structural challenges in direct-to-consumer mental health market.

“BetterHelp segment revenue decreased 9% year-over-year.”

Negative free cash flow and increased capex may pressure liquidity if trend persists.

“Free cash flow was an outflow of $26.3 million in First Quarter 2026, compared to an outflow of $15.7 million in First Quarter 2025.” · word for word
Read the original on SEC EDGAR ↗
7 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting; discloses executive compensation details, pay-for-performance alignment, and governance practices.open

Figures in the filing · each found in the filing text

Total revenue · FY2025$2.50B
Total adjusted EBITDA · FY2025$281M
Adjusted EBITDA margin · FY202511.1%
Cash and cash equivalents · FY2025$781M
Chronic care program enrollment · FY20251,200,000
BetterHelp unique users · BetterHelp · FY20251,300,000
Total visits · FY202517,100,000
Net loss · FY2025$-200M

Risks flagged

Performance shortfall risk

“ultimately our revenue and adjusted EBITDA performance fell short of these goals.” · word for word

Stock price volatility risk

“downward volatility in our stock price” · word for word

Customer acquisition cost pressure

“elevated customer acquisition costs, which we expected would continue to impact top line and overall financial performance in 2025” · word for word
Read the original on SEC EDGAR ↗
30 Mar 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
26 Feb 202610-KU.S. Integrated Care Members 101,800,000 (+9% y/y); Chronic Care Program Enrollment 1,190,000 (-1% y/y); Average Monthly Revenue Per U.S. Integrated Care Member $1.29 (-6% y/y); Guidance: Restructuring costs expected $15-20M in 2026open

Figures in the filing · each found in the filing text

U.S. Integrated Care Members · Integrated Care · FY2025101,800,000+9% y/y
Chronic Care Program Enrollment · Integrated Care · FY20251,190,000-1% y/y
Average Monthly Revenue Per U.S. Integrated Care Member · Integrated Care · FY2025$1.29-6% y/y
BetterHelp Paying Users · BetterHelp · FY2025390,000-5% y/y
Revenue · FY2025$2.53B-2% y/y
Net Loss · FY2025$-200M+80% y/y
Adjusted EBITDA · FY2025$281M-10% y/y
Integrated Care Revenue · Integrated Care · FY2025$1.58B+3% y/y
BetterHelp Revenue · BetterHelp · FY2025$950M-9% y/y
Goodwill Impairment · Integrated Care · FY2025$72M-91% y/y

Guidance

Restructuring costs expected $15-20M in 2026

No formal revenue or earnings guidance provided; restructuring guidance indicates ongoing cost pressures and margin headwinds.

Risks flagged

Goodwill Impairment Risk

“If the carrying value of the Integrated Care reporting unit exceeds its fair value as of the date of any future business combinations, the future business combinations that would be part of the Integrated Care reporting unit could result in further goodwill impairment charges.” · word for word

Tariff Cost Pressure

“We expect tariffs on goods imported into the U.S. from Canada, Mexico, and China...to continue to be met with retaliatory tariffs...which would impact our consolidated results of operations.” · word for word

BetterHelp User Decline

“BetterHelp paying users decreased by 5% to 0.39 million for the year ended December 31, 2025, compared to 0.41 million for the year ended December 31, 2024.” · word for word

Market Capitalization Decline Below Book Value

“In the period following December 31, 2025, there has been a decline in the Company’s market capitalization...below the Company’s carrying or book value. If this decline in the share price is sustained, it could require further testing of our goodwill in our next reporting period, which may result in an impairment.” · word for word
Read the original on SEC EDGAR ↗
25 Feb 20268-K · 2.02Revenue $642M (+0% y/y); Revenue $2.53B (-2% y/y); Net loss $-25M (+48% y/y)earningsopen

Figures in the filing · each found in the filing text

Revenue · Q4-2025$642M0% y/y
Revenue · FY2025$2.53B-2% y/y
Net loss · Q4-2025$-25M+48% y/y
Net loss · FY2025$-200M+80% y/y
Adjusted EBITDA · Q4-2025$84M+12% y/y
Adjusted EBITDA · FY2025$281M-10% y/y
Operating cash flow · FY2025$294M0% y/y
Free cash flow · FY2025$167M-2% y/y
Cash and cash equivalents · FY2025$781M
Integrated Care segment revenue · Integrated Care · Q4-2025$409M+5% y/y

Risks flagged

BetterHelp segment revenue and EBITDA declining; goodwill impairment charges.

“BetterHelp segment revenue down 9% FY; adjusted EBITDA down 46% FY; non-cash goodwill impairment of $71.8M.”

Restructuring costs continue; net loss persists.

“Restructuring costs of $18.8M in FY2025; net loss of $200.3M.”
Read the original on SEC EDGAR ↗
18 Feb 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
12 Feb 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

Loss of long-tenured board member

“Mr. McKinley has been a director of the Company since 2009” · word for word
Read the original on SEC EDGAR ↗
16 Dec 20258-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
12 Dec 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

Potential dilution from increased share reserve for employee inducement awards.

“increase the number of shares of common stock... reserved for issuance under the 2023 Inducement Plan by 1,780,000 shares” · word for word
Read the original on SEC EDGAR ↗
30 Oct 202510-QTeladoc Health reported Q3 2025 revenue down 2% YoY, with BetterHelp segment declining 8% and Integrated Care growing 2%; net loss widened to $49.5M from $33.3M; goodwill impairment of $12.6M.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$626M-2% y/y
Net loss · Q3-2025$-50M+49% y/y
Adjusted EBITDA · Q3-2025$70M-16% y/y
Free cash flow · 9M-2025$113M+0% y/y
U.S. Integrated Care members · Integrated Care · Q3-2025102,500,000+9% y/y
Chronic care program enrollment · Integrated Care · Q3-20251,165,000-1% y/y
Average monthly revenue per U.S. Integrated Care member · Integrated Care · Q3-2025$1.27-7% y/y
BetterHelp paying users · BetterHelp · Q3-2025382,000-4% y/y
Integrated Care revenue · Integrated Care · Q3-2025$390M+2% y/y
BetterHelp revenue · BetterHelp · Q3-2025$237M-8% y/y

Risks flagged

Goodwill impairment risk from acquisitions

“If the carrying value of the Integrated Care reporting unit continues to exceed its fair value, any future business combinations that would be part of the Integrated Care reporting unit could result in further goodwill impairment charges.” · word for word

Tariff cost pressure on imported components

“We expect tariffs on goods imported into the U.S. from Canada, Mexico, and China...to impact our consolidated results of operations as we import components for assembling welcome kits, refill kits, and replacement components for our chronic care management solutions and virtual healthcare devices manufactured for sale or lease as part of our hosted virtual h” · word for word

BetterHelp revenue decline and margin compression

“BetterHelp total revenue decreased by $19.9 million, or 8%, to $236.9 million for the three months ended September 30, 2025...BetterHelp Adjusted EBITDA Margin % 1.6% for Q3 2025 vs 5.9% for Q3 2024.” · word for word
Read the original on SEC EDGAR ↗
29 Oct 20258-K · 2.02Revenue $626M (-2% y/y); Net loss $-50M (+49% y/y); Net loss per share $-0.28 (+47% y/y)earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$626M-2% y/y
Net loss · Q3-2025$-50M+49% y/y
Net loss per share · Q3-2025$-0.28+47% y/y
Adjusted EBITDA · Q3-2025$70M-16% y/y
Integrated Care segment revenue · Integrated Care · Q3-2025$390M+2% y/y
BetterHelp segment revenue · BetterHelp · Q3-2025$237M-8% y/y
Cash flow from operations · Q3-2025$99M-10% y/y
Capital expenditures and capitalized software development costs · Q3-2025$31M+1% y/y
Free cash flow · Q3-2025$68M-14% y/y

Risks flagged

Goodwill impairment risk due to Integrated Care segment fair value below carrying value

“non-cash goodwill impairment charge of $12.6 million...fair value of the Integrated Care segment being less than its carrying value at the time of the acquisition of Telecare Australia”

BetterHelp segment revenue decline and margin compression

“BetterHelp segment revenue decreased 8% to $236.9 million...BetterHelp segment adjusted EBITDA decreased 75% to $3.8 million” · word for word

Restructuring costs continuing

“Net loss for Third Quarter 2025 also included $2.0 million...of restructuring costs related to severance costs and costs associated with office space reductions” · word for word
Read the original on SEC EDGAR ↗

Teladoc Health, Inc. — questions

What did Teladoc Health, Inc. file recently?
18 SEC filings in the last 12 months. Latest: 8-K on 2026-09-25 — Chief Legal Officer Adam Vandervoort resigns effective Nov 1, 2026; will provide advisory services until Nov 1, 2027. Successor Jonathan Dorfman appointed. Resignation with good reason under severance agreement.

Every figure on this page comes from Teladoc Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.